Regional citrate anticoagulation (RCA) is now recommended over systemic heparin for continuous renal replacement therapy in patients without contraindications. Its use is likely to increase throughout the world. However, in the absence of citrate blood level monitoring, the diagnosis of citrate accumulation, the most feared complication of RCA, remains relatively complex. It is therefore commonly mistaken with other conditions. This review aims at providing clarifications on RCA-associated acid-base disturbances and their management at the bedside. In particular, the authors wish to propose a clear distinction between citrate accumulation and net citrate overload
Background: Regional citrate anticoagulation (RCA) is an effective form of anticoagulation for conti...
Regional citrate anticoagulation is now widely used during continuous renal replacement therapy (CRR...
Purpose: Continuous renal replacement therapy (CRRT) is commonly used in the care of critically ill ...
Abstract Regional citrate anticoagulation (RCA) is now recommended over systemic heparin for continu...
Regional citrate anticoagulation (RCA) is the recommended anticoagulation modality for continuous re...
Introduction Regional citrate anticoagulation (RCA) is the recommended anticoagulation modality for ...
Regional citrate anticoagulation (RCA) is proposed for various extracorporeal purification technique...
Regional citrate anticoagulation (RCA) is proposed for various extracorporeal purification technique...
Abstract Background Regional citrate anticoagulation (RCA) for the prevention of clotting of the ext...
Background: Heparins are used for circuit anticoagulation during continuous renal replacement therap...
Background: Heparins are used for circuit anticoagulation during continuous renal replacement therap...
A systemic anticoagulation is often required to prevent circuit and filter clotting in ICU patients ...
Objective: To investigate the efficacy and safety of regional citrate anticoagulation (RCA) in cont...
Introduction: Regional citrate anticoagulation (RCA) is a valid option in patients at high risk of b...
Hemorrhagic complications have been reported in up to 30% of critically ill patients with AKI underg...
Background: Regional citrate anticoagulation (RCA) is an effective form of anticoagulation for conti...
Regional citrate anticoagulation is now widely used during continuous renal replacement therapy (CRR...
Purpose: Continuous renal replacement therapy (CRRT) is commonly used in the care of critically ill ...
Abstract Regional citrate anticoagulation (RCA) is now recommended over systemic heparin for continu...
Regional citrate anticoagulation (RCA) is the recommended anticoagulation modality for continuous re...
Introduction Regional citrate anticoagulation (RCA) is the recommended anticoagulation modality for ...
Regional citrate anticoagulation (RCA) is proposed for various extracorporeal purification technique...
Regional citrate anticoagulation (RCA) is proposed for various extracorporeal purification technique...
Abstract Background Regional citrate anticoagulation (RCA) for the prevention of clotting of the ext...
Background: Heparins are used for circuit anticoagulation during continuous renal replacement therap...
Background: Heparins are used for circuit anticoagulation during continuous renal replacement therap...
A systemic anticoagulation is often required to prevent circuit and filter clotting in ICU patients ...
Objective: To investigate the efficacy and safety of regional citrate anticoagulation (RCA) in cont...
Introduction: Regional citrate anticoagulation (RCA) is a valid option in patients at high risk of b...
Hemorrhagic complications have been reported in up to 30% of critically ill patients with AKI underg...
Background: Regional citrate anticoagulation (RCA) is an effective form of anticoagulation for conti...
Regional citrate anticoagulation is now widely used during continuous renal replacement therapy (CRR...
Purpose: Continuous renal replacement therapy (CRRT) is commonly used in the care of critically ill ...